Primary CD5-negative intrathyroidal thymic carcinoma with neuroendocrine differentiation and lymph node metastasis acquiring CD5 expression:case report
Lijun Wen, Li Zhou, Min Wang, Guangzhen Ma, Wei Hong · 2026
Read Primary CD5-negative intrathyroidal thymic carcinoma with neuroendocrine differentiation and lymph node metastasis acquiring CD5 expression:case report by Lijun Wen, Li Zhou, Min Wang, Guangzhen Ma, Wei Hong (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13292294.txt.
Description
Lijun Wen and co-authors recount a 2026 diagnostically tricky case of intrathyroidal thymic carcinoma, a tumor making up under 0.15 percent of thyroid cancers. It usually betrays itself through CD5 and CD117 staining, but exceptions unsettle that rule. Their patient, a 32-year-old Chinese woman seen in 2019, arrived with hoarseness, swallowing trouble, and a firm left thyroid mass.
Imaging showed a lesion of about 4.1 cm in the left lobe plus a tiny right-side nodule, and her left vocal cord was paralyzed. After total thyroid removal and neck dissection, pathology showed CD117, p63, and p40 positivity but no CD5, still fitting the thymic carcinoma diagnosis. A separate papillary thyroid cancer coexisted. The tumor later returned in lymph nodes and, strikingly, gained CD5 expression, which the authors read as clonal evolution.
Catalog record
| CREATOR | Lijun Wen, Li Zhou, Min Wang, Guangzhen Ma, Wei Hong |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 14204 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |